SCHEMBL5867513

SCHEMBL5867513

COc1ccc(OC)c(CC(=O)Nc2cc(C3CC3)n[nH]2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLS O94925 2/20 0.48
SIGMAR1 Q99720 1/20 0.48
AURKA O14965 1/20 0.48
AURKB Q96GD4 1/20 0.48
HSD17B10 Q99714 1/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
MAPK8 P45983 3/20 0.46
MAPK9 P45984 2/20 0.46
CDK2 P24941 4/20 0.45
CCNA2 P20248 1/20 0.45
CCNA1 P78396 1/20 0.45
CDK9 P50750 1/20 0.44
CDK5 Q00535 1/20 0.44
CSNK1D P48730 1/20 0.43
RPS6KB1 P23443 1/20 0.42
MAPK1 P28482 1/20 0.42
MAPK10 P53779 1/20 0.42
PRKD2 Q9BZL6 1/20 0.42
RPS6KB2 Q9UBS0 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5867393 0.84 CDK2 (0.60) KMT2AMEN1MAPK8MAPK9CDK2
SCHEMBL5867452 0.83 MTNR1A (0.54) SIGMAR1HSD17B10KMT2AMEN1RAB9A
SCHEMBL5867989 0.83 ALPL (0.55) GLSSIGMAR1KMT2AMEN1CDK2
SCHEMBL5868067 0.82 CDK2 (0.67) GLSSIGMAR1KMT2AMEN1MAPK8
SCHEMBL6390325 0.81 CDK2 (0.46) GLSKMT2AMEN1CDK2CDK9
SCHEMBL5867660 0.81 CFTR (0.44) SIGMAR1KMT2AMEN1CDK2CCNA2
SCHEMBL5868099 0.81 CDK2 (0.69) CDK2CCNA2CCNA1CDK9CDK5
SCHEMBL13376907 0.80 GLS (0.48) GLSAURKAAURKBHSD17B10KMT2A
SCHEMBL7920085 0.79 NPC1 (0.50) AURKBHSD17B10KMT2AMEN1CDK2
SCHEMBL5868042 0.76 CCNA2 (0.63) KMT2AMEN1CDK2CCNA2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7034049-B1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents PHARMACIA ITALIA S.P.A. (IT) 2006-04-25 US disclosed
EP-1202733-B1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-10-05 EP disclosed
EP-1202733-A4 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2003-05-14 EP disclosed
EP-1202733-A1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS Pharmacia Italia S.p.A. (IT) 2002-05-08 EP disclosed
US-6218418-B1 THERAPY OF CELL PROLIFERATIVE DISORDERS ASSOCIATED WITH AN ALTERED CELL DEPENDENT KINASE ACTIVITY BY ADMINISTERING AMINO PYRAZOLE DERIVATIVE TO MAMMAL PHARMACIA & UPJOHN S.P.A (IT) 2001-04-17 US disclosed
WO-2001012189-A1 3(5)-AMINO-PYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR AGENTS PHARMACIA ITALIA S.P.A. (IT) 2001-02-22 WO disclosed